These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7105643)

  • 21. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial of tibric acid, a new hypolipidemic agent].
    Noseda G; Sirtori CR
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
    [No Abstract]   [Full Text] [Related]  

  • 23. [Which antilipemic agent when?].
    Schwandt P
    Internist (Berl); 1989 Sep; 30(9):625. PubMed ID: 2807786
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
    Warembourg H; Ketelers JY; Ginestet A
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing hyperlipidaemia.
    Nestel PJ
    Med J Aust; 1988 Jan; 148(1):29-31. PubMed ID: 3336296
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacotherapy of hyperlipoproteinemias: indications, mechanisms of action, effectiveness and side effects].
    Schernthaner G; Woschnagg H
    Wien Med Wochenschr; 1990 Feb; 140(3):64-75. PubMed ID: 2180212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypercholesterolemia and the diagnosis and management of hyper- lipidemia in adults. Recommendations of the working groups of the Finnish Society of Internal Medicine and the Finnish Cardiology Society].
    Duodecim; 1988; 104(18):1425-38. PubMed ID: 3181045
    [No Abstract]   [Full Text] [Related]  

  • 29. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A; Aguilar-Salinas CA
    Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental study of the hypolipidemic effect of tiadenol].
    Accarino G; Barone L; Chieppa S; Giusti I; Nutile T; Luppino E; Visone C
    Boll Chim Farm; 1979 Dec; 118(12):739-47. PubMed ID: 552256
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialty clinic.
    Rindone JP; Arriola OG
    Pharmacotherapy; 1997; 17(6):1296-9. PubMed ID: 9399614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 33. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias].
    Palmieri G; Perego M; Nazzari M; Casalini F
    Clin Ter; 1982 Jun; 101(6):603-14. PubMed ID: 7128029
    [No Abstract]   [Full Text] [Related]  

  • 35. [A study of the effect of some hypolipidemic substances].
    Synková J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1978; 21(4):401-25. PubMed ID: 316922
    [No Abstract]   [Full Text] [Related]  

  • 36. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.
    Nordøy A
    Minerva Med; 2002 Oct; 93(5):357-63. PubMed ID: 12410168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperlipidemia: outpatient management.
    Schattenberg TT
    Cardiovasc Clin; 1980; 10(3):247-55. PubMed ID: 7379078
    [No Abstract]   [Full Text] [Related]  

  • 38. [Efficacy of procetofen (lipanthyl) in hyperlipidemias (author's transl)].
    Stähelin HB; Seiler W; Pult N
    Schweiz Rundsch Med Prax; 1979 Jan; 68(1):24-8. PubMed ID: 760103
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dyslipoproteinemias: treatment with lipid regulating drugs].
    Schwandt P
    Fortschr Med; 1990 Feb; 108(6):97-9. PubMed ID: 2323709
    [No Abstract]   [Full Text] [Related]  

  • 40. [Familial hypercholesterolemia. Screening, prevention and therapeutic possibilities].
    Vierucci A; Biadaioli R; De Martino M; Pratesi F; Novembre E; Morotti P
    Minerva Pediatr; 1982 Apr; 34(8):325-36. PubMed ID: 7048049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.